Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
H&R GmbH KGaALTS:0RRC 65 14-Day RSI is 76.90 as of Jul. 25, 2026. GuruFocus rates LTS:0RRC with a GF Score™ of 65/100 and a GF Value™ of €4.10 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,651 Chemicals companies, H&R GmbH KGaA ranks worse than 97.82% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-25), H&R GmbH KGaA's 14-Day RSI is 76.90.
The industry rank for H&R GmbH KGaA's 14-Day RSI or its related term are showing as below:
LTS:0RRC's 14-Day RSI is ranked worse than 97.82% of 1651
companies
in the Chemicals industry
Industry Median: 45.68
vs LTS:0RRC: 76.90
H&R GmbH KGaA (LTS:0RRC) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
H&R GmbH KGaA 14-Day RSI Related Terms
LTS:0RRC vs LIN, SHW, ECL: 14-Day RSI Comparison
For the Specialty Chemicals subindustry, H&R GmbH KGaA's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H&R GmbH KGaA 14-Day RSI vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, H&R GmbH KGaA's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where H&R GmbH KGaA's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H&R GmbH KGaA (LTS:0RRC) has a 14-Day RSI of 76.90 as of Jul. 25, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on H&R GmbH KGaA and its competitors. According to the industry distribution chart, H&R GmbH KGaA ranks #1615 out of 1651 companies in the Chemicals industry, placing it in the top 97.8%.
Is H&R GmbH KGaA's 14-Day RSI too high?
H&R GmbH KGaA's current 14-Day RSI is 76.90. The Chemicals industry median 14-Day RSI is 45.68. H&R GmbH KGaA's value of 76.90 is 68.3% above this industry median. Based on the distribution chart, H&R GmbH KGaA ranks #1615 out of 1651 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, H&R GmbH KGaA has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H&R GmbH KGaA's 14-Day RSI compare to LIN and SHW?
According to the Chemicals industry distribution chart, H&R GmbH KGaA ranks #1615 out of 1651 companies for 14-Day RSI. This places H&R GmbH KGaA in the lower half of its industry. The industry median 14-Day RSI is 45.68. H&R GmbH KGaA's value of 76.90 is 68.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Chemicals company?
The median 14-Day RSI among Chemicals companies is 45.68, based on 1,651 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. H&R GmbH KGaA's current 14-Day RSI of 76.90 is 68.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on H&R GmbH KGaA and its competitors. For the Chemicals industry, the median 14-Day RSI is 45.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H&R GmbH KGaA's current 14-Day RSI is 76.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H&R GmbH KGaA stock overvalued right now?
Based on GuruFocus' analysis, H&R GmbH KGaA (LTS:0RRC) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.10, compared to a current price of €6.44 — trading 57.1% above its estimated fair value. The current 14-Day RSI is 76.90 and 68.3% above the Chemicals industry median of 45.68. H&R GmbH KGaA's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For H&R GmbH KGaA (LTS:0RRC), the current 14-Day RSI is 76.90 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H&R GmbH KGaA (LTS:0RRC) Overvalued in 2026?
Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued.
The current stock price of €6.44 is trading 57.1% above its estimated GF Value™ of €4.10.
GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.
Key valuation signals for LTS:0RRC:
14-Day RSI: 76.90
GF Value™: €4.10 vs. price of €6.44 (57.1% above fair value)
Industry Position: 68.3% above the Chemicals median (#1615 of 1651)
No single metric tells the full story. See the LTS:0RRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
65GF Score
Get the complete analysis for LTS:0RRC
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RRC has been successfully added to your 
